CDC Website CDC Website

To Join the NPIN community or

Home » "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)

"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)

The purpose of this funding opportunity announcement (FOA) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals.

Fund Location Notes
Eligible Organizations
Number of Awards Given
Varies

Minimum Amount: 

$0.00

Maximum Amount: 

$0.00

Average Amount: 

$0.00

Award Amount: 

$0.00
Award Amount Notes
Notes
Companion Funding Opportunity-PA-16-425, R21 Exploratory/Developmental Grant
Letter of Intent Date
9/14/16
Application Due Date
9/7/19
Award Date
9/14/16
Open Ended Date
9/14/16
Project Start Date
9/14/16
Application Contact
Elizabeth
Read-Connole, Ph.D.
United States
(240) 276-6226
bconnole@mail.nih.gov
(240) 276-6226
Technical Contact
GrantsInfo
GrantsInfo@nih.gov
United States
(301) 710-0267
(301) 710-0267
Fund Duration
The maximum project period is 5 years.
Subjects
Audiences
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Focus Area

Fund Number: 

PA-16-426

Fund ID: 

5200

Last Updated: 

9/14/16